VAERS 1820541
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN0203
- Staat
- PA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 27.10.2021
- Impfdatum
- 02.03.2021
- Beginn
- 16.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- OT / RA
Symptomtext
This is a spontaneous report from a contactable Physician. This Physician reported for a 80-year-old female patient that: A 80-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: EN0203), via intramuscular route, administered right arm as dose 2, single on 02Mar2021 11:00 (at the age of 80-year-old) for covid-19 immunisation at hospital. Medical history included hypertension from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication included amlodipine besilate (NORVASC) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: E18982), via intramuscular route, administered right arm as dose 1, single on 09Feb2021 11:00 (at the age of 80-year-old) for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications within 2 weeks of vaccination was Norvasc. Patient had not been diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. ON 16Mar2021, the patient has had a persistent diffuse body rash that was very pruritic. It began as urticarial rash then those resolved but she had small nodules under her skin and then a popular diffuse rash appeared and was persisted. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 15Jun2021. Therapeutic measures were taken as a result of adverse events with steroids after 4 weeks of persistent rash and now antihistamines. Adverse event resulted in doctor or other healthcare professional office/clinic visit. At the time of this report, the outcome of event urticarial rash was recovered on unspecified date in 2021; the outcome of all other events was not recovered. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash pruritic
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210615; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypertension
- Andere Medikamente
- NORVASC
- Allergien
- -
- Vorherige Impfungen
- -